Envestnet Asset Management
RGNX icon

Envestnet Asset Management’s Regenxbio RGNX Stock Holding History

Envestnet Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31,175
Closed -$225K – 4063
2023
Q1 		$225K Sell
31,175
-2,038
-6% -$45.1K ﹤0.01% 3598
2022
Q4 		$753K Buy
33,213
+6,423
+24% +$145K ﹤0.01% 2844
2022
Q3 		$708K Buy
26,790
+13,137
+96% +$390K ﹤0.01% 2807
2022
Q2 		$337K Buy
13,653
+5,170
+61% +$129K ﹤0.01% 3293
2022
Q1 		$282K Buy
8,483
+804
+10% +$22.3K ﹤0.01% 3492
2021
Q4 		$251K Buy
7,679
+745
+11% +$25.4K ﹤0.01% 3518
2021
Q3 		$291K Buy
+6,934
New +$250K ﹤0.01% 3310

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Envestnet Asset Management's RGNX Position: Q2 2023 in Review

Envestnet Asset Management sold out of Regenxbio (RGNX) in Q2 2023, closing a stake of 31,175 shares — an estimated $225K sold.

Envestnet Asset Management first reported a position in RGNX in Q3 2021 and held it in 7 quarters. The position peaked at $753K in Q4 2022. 166 funds tracked by Wall St. Rank hold RGNX as of Q2 2023.

  • Envestnet Asset Management reported no remaining Regenxbio position as of Q2 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 31,175 Regenxbio shares in Q2 2023, an estimated $225K.
  • Envestnet Asset Management first reported a position in Regenxbio in Q3 2021 and held it in 7 quarters.
  • Envestnet Asset Management's Regenxbio position peaked at $753K in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q2 2023.

Based on Envestnet Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.